# Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer

> **NCT04835025** · — · SUSPENDED · sponsor: **Tongji Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** PD-1/PD-L1 inhibitor

## Key facts

- **NCT ID:** NCT04835025
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-01-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 200 (ESTIMATED)
- **Why stopped:** because of COVID-19
- **Last updated:** 2021-04-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04835025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04835025, "Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04835025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*